Protalix Biotherapeutics
Protalix is a biopharmaceutical company that is revolutionizing the development and manufacturing of recombinant therapeutic proteins.
Protalix Biotherapeutics has raised €36M across 1 funding round, most recently a round in Dec 2020. Based in Carmiel, Israel; founded 1994; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€36M
€36,217,471
Funding rounds
1
Investors
0
distinct backers
Active since
2020-12
latest 2020-12
Funding by year
EUR raised per yearProtalix Biotherapeutics — funding by year — interactive chart.
Data table
| Protalix Biotherapeutics — funding by year | |
|---|---|
| 2020 | €36M |
Signals
Medium confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-12-03 | Other | €36M | — | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Trax€789MIsrael · Software
Global coverage: FundingData